Oncologic surveillance after curative treatment: A probability-based approach should be preferred to a risk-based approach

Affiliations

¹ Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse-Oncopole, Toulouse, France; Département de Recherche Clinique, Centre MURAZ, Bobo-Dioulasso, Burkina Faso.
² Département d׳Oncologie Médicale, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse-Oncopole, Toulouse, France.
³ TSE (GREMAQ), Université Toulouse 1 Capitole, Toulouse, France.
⁴ Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse-Oncopole, Toulouse, France. Electronic address: filleron.thomas@iuct-oncopole.fr.

Comment

Serge M A Somda et al. Urol Oncol. 2016 May.

. 2016 May;34(5):244-5.

doi: 10.1016/j.urolonc.2016.02.026. Epub 2016 Mar 30.

¹ Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse-Oncopole, Toulouse, France; Département de Recherche Clinique, Centre MURAZ, Bobo-Dioulasso, Burkina Faso.
² Département d׳Oncologie Médicale, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse-Oncopole, Toulouse, France.
³ TSE (GREMAQ), Université Toulouse 1 Capitole, Toulouse, France.
⁴ Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse-Oncopole, Toulouse, France. Electronic address: filleron.thomas@iuct-oncopole.fr.

No abstract available

Comment on

Evaluation of current surveillance guidelines following radical cystectomy and proposal of a novel risk-based approach.
Stewart-Merrill SB, Boorjian SA, Thompson RH, Psutka SP, Cheville JC, Thapa P, Bergstrahl EJ, Tollefson MK, Frank I. Stewart-Merrill SB, et al. Urol Oncol. 2015 Aug;33(8):339.e1-8. doi: 10.1016/j.urolonc.2015.04.017. Epub 2015 May 29. Urol Oncol. 2015. PMID: 26031371